肝细胞癌中的作用及其机制

作者：张馨予

参考文献 TORRE L A, SIEGEL R L, WARD E M, et al. Global cancer incidence and mortality rates and trends: an update[J]. Cancer Epidemiol Biomarkers Prev, 2016, 25(1): 16–27. DOI:10.1158/1055-9965.EPI-15-0578
PARKIN D M. The global health burden of infection-associated cancers in the year 2002[J]. Int J Cancer, 2006, 118(12): 3030–3044. DOI:10.1002/ijc.21731
OKAZAKI Y, FURUNO M, KASUKAWA T, et al. Analysis of the mouse transcriptome based on functional annotation of 60, 770 full-length cDNAs[J]. Nature, 2002, 420(6915): 563–573. DOI:10.1038/nature01266
GUTTMAN M, RINN J L. Modular regulatory principles of large non-coding RNAs[J]. Nature, 2012, 482(7385): 339–346. DOI:10.1038/nature10887
TRIPATHI V, SHEN Z, CHAKRABORTY A, et al. Long noncoding RNA MALAT1 controls cell cycle progression by regulating the expression of oncogenic transcription factor B-MYB[J]. PLoS Genet, 2013, 9(3): e1003368. DOI:10.1371/journal.pgen.1003368
BATISTA P J, CHANG H Y. Long noncoding RNAs: cellular address codes in development and disease[J]. Cell, 2013, 152(6): 1298–1307. DOI:10.1016/j.cell.2013.02.012
CHAUHAN R, LAHIRI N. Tissue- and serum-associated biomarkers of hepatocellular carcinoma[J]. Biomark Cancer, 2016, 8(Suppl 1): 37–55. DOI:10.4137/BIC.S34413
PARASRAMKA M A, MAJI S, MATSUDA A, et al. Long non-coding RNAs as novel targets for therapy in hepatocellular carcinoma[J]. Pharmacol Ther, 2016, 161: 67–78. DOI:10.1016/j.pharmthera.2016.03.004
HUANG J L, REN T Y, CAO S W, et al. HBx-related long non-coding RNA DBH-AS1 promotes cell proliferation and survival by activating MAPK signaling in hepatocellular carcinoma[J]. Oncotarget, 2015, 6(32): 33791–33804. DOI:10.18632/oncotarget.5667
DU Y, KONG G, YOU X, et al. Elevation of highly up-regulated in liver cancer (HULC) by hepatitis B virus X protein promotes hepatoma cell proliferation via down-regulating p18[J]. J Biol Chem, 2012, 287(31): 26302–26311. DOI:10.1074/jbc.M112.342113
HUANG J F, GUO Y J, ZHAO C X, et al. Hepatitis B virus X protein (HBx)-related long noncoding RNA (lncRNA) down-regulated expression by HBx (Dreh) inhibits hepatocellular carcinoma metastasis by targeting the intermediate filament protein vimentin[J]. Hepatology, 2013, 57(5): 1882–1892. DOI:10.1002/hep.26195
YUAN S X, WANG J, YANG F, et al. Long noncoding RNA DANCR increases stemness features of hepatocellular carcinoma by derepression of CTNNB1[J]. Hepatology, 2016, 63(2): 499–511. DOI:10.1002/hep.27893
涂晓丽, 文荃, 闫军. HBV+肝细胞癌患者lncRNA-mRNA共表达网络分析及作用[J]. 第三军医大学学报, 2018, 40(1): 37–44.
TU X L, WEN Q, YAN J. Profiles and functions of lncRNA-mRNA co-expression network in HBV+ hepatocellular carcinoma patients[J]. J Third Med Univ, 2018, 40(1): 37–44. DOI:10.16016/j.1000-5404.201708015
WEN Q, YANG Y, CHEN X, et al. Competing endogenous RNA screening based on lncRNA-mRNA co-expression profile in HBV-associated hepatocarcinogenesis[J]. J Tradit Chin Med, 2017, 37(4): 510–521. DOI:10.1016/s0254-6272(17)60108-0
LIU N, LIU X, ZHOU N, et al. Gene expression profiling and bioinformatics analysis of gastric carcinoma[J]. Exp Mol Pathol, 2014, 96(3): 361–366. DOI:10.1016/j.yexmp.2014.02.007
HUANG D A W, SHERMAN B T, LEMPICKI R A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources[J]. Nat Protoc, 2009, 4(1): 44–57. DOI:10.1038/nprot.2008.211
YU G, WANG L G, HAN Y, et al. clusterProfiler: an R package for comparing biological themes among gene clusters[J]. OMICS, 2012, 16(5): 284–287. DOI:10.1089/omi.2011.0118
TAN G, LENHARD B. TFBSTools: an R/bioconductor package for transcription factor binding site analysis[J]. Bioinformatics, 2016, 32(10): 1555–1556. DOI:10.1093/bioinformatics/btw024
KHAN A, FORNES O, STIGLIANI A, et al. JASPAR 2018: update of the open-access database of transcription factor binding profiles and its web framework[J]. Nucleic Acids Res, 2018, 46(D1): D1284. DOI:10.1093/nar/gkx1188
SUN X, HAN Q, LUO H, et al. Profiling analysis of long non-coding RNAs in early postnatal mouse hearts[J]. Sci Rep, 2017, 7: 43485. DOI:10.1038/srep43485
LIU Z, CHEN Z, FAN R, et al. Over-expressed long noncoding RNA HOXA11-AS promotes cell cycle progression and metastasis in gastric cancer[J]. Mol Cancer, 2017, 16(1): 82. DOI:10.1186/s12943-017-0651-6
LUPBERGER J, HILDT E. Hepatitis B virus-induced oncogenesis[J]. World J Gastroenterol, 2007, 13(1): 74–81. DOI:10.3748/wjg.v13.i1.74
LIU T, WEI J, JIANG C, et al. CHAF1A, the largest subunit of the chromatin assembly factor 1 complex, regulates the growth of H1299 human non-small cell lung cancer cells by inducing G0/G1 cell cycle arrest[J]. Exp Ther Med, 2017, 14(5): 4681–4686. DOI:10.3892/etm.2017.5201
MJELLE R, HEGRE S A, AAS P A, et al. Cell cycle regulation of human DNA repair and chromatin remodeling genes[J]. DNA Repair (Amst), 2015, 30: 53–67. DOI:10.1016/j.dnarep.2015.03.007
XU M, JIA Y, LIU Z, et al. Chromatin assembly factor 1, subunit A (P150) facilitates cell proliferation in human hepatocellular carcinoma[J]. Onco Targets Ther, 2016, 9: 4023–4035. DOI:10.2147/OTT.S107050
TSENG Y H, HUANG Y H, LIN T K, et al. Thyroid hormone suppresses expression of stathmin and associated tumor growth in hepatocellular carcinoma[J]. Sci Rep, 2016, 6: 38756. DOI:10.1038/srep38756
SU M C, HSU H C, LIU Y J, et al. Overexpression of pituitary tumor-transforming gene-1 in hepatocellular carcinoma[J]. Hepatogastroenterology, 2006, 53(68): 262–265.
MOLINA-JIMENEZ F, BENEDICTO I, MURATA M, et al. Expression of pituitary tumor-transforming gene 1 (PTTG1)/ securin in hepatitis B virus (HBV)-associated liver diseases: evidence for an HBV X protein-mediated inhibition of PTTG1 ubiquitination and degradation[J]. Hepatology, 2010, 51(3): 777–787. DOI:10.1002/hep.23468
CHEN Y L, UEN Y H, LI C F, et al. The E2F transcription factor 1 transactives stathmin 1 in hepatocellular carcinoma[J]. Ann Surg Oncol, 2013, 20(12): 4041–4054. DOI:10.1245/s10434-012-2519-8
ZHOU C, WAWROWSKY K, BANNYKH S, et al. E2F1 induces pituitary tumor transforming gene (PTTG1) expression in human pituitary tumors[J]. Mol Endocrinol, 2009, 23(12): 2000–2012. DOI:10.1210/me.2009-0161
STANELLE J, STIEWE T, THESELING C C, et al. Gene expression changes in response to E2F1 activation[J]. Nucleic Acids Res, 2002, 30(8): 1859–1867. DOI:10.1093/nar/30.8.1859
FARRA R, GRASSI G, TONON F, et al. The role of the transcription factor E2F1 in hepatocellular carcinoma[J]. Curr Drug Deliv, 2017, 14(2): 272–281. DOI:10.2174/1567201813666160527141742